326 related articles for article (PubMed ID: 30401776)
1. Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency.
Kyei GB; Meng S; Ramani R; Niu A; Lagisetti C; Webb TR; Ratner L
mBio; 2018 Nov; 9(6):. PubMed ID: 30401776
[TBL] [Abstract][Full Text] [Related]
2. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.
Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D
mBio; 2016 Jul; 7(4):. PubMed ID: 27381288
[TBL] [Abstract][Full Text] [Related]
3. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
[TBL] [Abstract][Full Text] [Related]
4. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.
Boehm D; Calvanese V; Dar RD; Xing S; Schroeder S; Martins L; Aull K; Li PC; Planelles V; Bradner JE; Zhou MM; Siliciano RF; Weinberger L; Verdin E; Ott M
Cell Cycle; 2013 Feb; 12(3):452-62. PubMed ID: 23255218
[TBL] [Abstract][Full Text] [Related]
5. SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4
Antonucci JM; Kim SH; St Gelais C; Bonifati S; Li TW; Buzovetsky O; Knecht KM; Duchon AA; Xiong Y; Musier-Forsyth K; Wu L
J Virol; 2018 Aug; 92(15):. PubMed ID: 29793958
[TBL] [Abstract][Full Text] [Related]
6. NUCKS1, a novel Tat coactivator, plays a crucial role in HIV-1 replication by increasing Tat-mediated viral transcription on the HIV-1 LTR promoter.
Kim HY; Choi BS; Kim SS; Roh TY; Park J; Yoon CH
Retrovirology; 2014 Aug; 11():67. PubMed ID: 25116364
[TBL] [Abstract][Full Text] [Related]
7. HEXIM1-Tat chimera inhibits HIV-1 replication.
Leoz M; Kukanja P; Luo Z; Huang F; Cary DC; Peterlin BM; Fujinaga K
PLoS Pathog; 2018 Nov; 14(11):e1007402. PubMed ID: 30395647
[TBL] [Abstract][Full Text] [Related]
8. Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression.
Wilhelm E; Poirier M; Da Rocha M; Bédard M; McDonald PP; Lavigne P; Hunter CL; Bell B
PLoS Pathog; 2024 May; 20(5):e1011821. PubMed ID: 38781120
[TBL] [Abstract][Full Text] [Related]
9. Identification of HIV-1 Tat-Associated Proteins Contributing to HIV-1 Transcription and Latency.
Jean MJ; Power D; Kong W; Huang H; Santoso N; Zhu J
Viruses; 2017 Apr; 9(4):. PubMed ID: 28368303
[TBL] [Abstract][Full Text] [Related]
10. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
[TBL] [Abstract][Full Text] [Related]
11. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
Quivy V; De Walque S; Van Lint C
Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
[TBL] [Abstract][Full Text] [Related]
12. FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency.
Huang H; Santoso N; Power D; Simpson S; Dieringer M; Miao H; Gurova K; Giam CZ; Elledge SJ; Zhu J
J Biol Chem; 2015 Nov; 290(45):27297-27310. PubMed ID: 26378236
[TBL] [Abstract][Full Text] [Related]
13. Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors.
Sgarbanti M; Borsetti A; Moscufo N; Bellocchi MC; Ridolfi B; Nappi F; Marsili G; Marziali G; Coccia EM; Ensoli B; Battistini A
J Exp Med; 2002 May; 195(10):1359-70. PubMed ID: 12021315
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.
Mbonye U; Karn J
Virology; 2014 Apr; 454-455():328-39. PubMed ID: 24565118
[TBL] [Abstract][Full Text] [Related]
15. Nucleolar protein NOP2/NSUN1 suppresses HIV-1 transcription and promotes viral latency by competing with Tat for TAR binding and methylation.
Kong W; Biswas A; Zhou D; Fiches G; Fujinaga K; Santoso N; Zhu J
PLoS Pathog; 2020 Mar; 16(3):e1008430. PubMed ID: 32176734
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of latently infected HIV-1 viral reservoirs and correction of aberrant alternative splicing in the LMNA gene via AMPK activation: Common mechanism of action linking HIV-1 latency and Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2015 Sep; 85(3):320-32. PubMed ID: 26115946
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant.
Balboni PG; Bozzini R; Zucchini S; Marconi PC; Grossi MP; Caputo A; Manservigi R; Barbanti-Brodano G
J Med Virol; 1993 Dec; 41(4):289-95. PubMed ID: 8106862
[TBL] [Abstract][Full Text] [Related]
18. SF3B1 is a stress-sensitive splicing factor that regulates both HSF1 concentration and activity.
Kim Guisbert KS; Guisbert E
PLoS One; 2017; 12(4):e0176382. PubMed ID: 28445500
[TBL] [Abstract][Full Text] [Related]
19. Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switch.
Venkatachari NJ; Zerbato JM; Jain S; Mancini AE; Chattopadhyay A; Sluis-Cremer N; Bar-Joseph Z; Ayyavoo V
Retrovirology; 2015 Oct; 12():85. PubMed ID: 26438393
[TBL] [Abstract][Full Text] [Related]
20. Balanced splicing at the Tat-specific HIV-1 3'ss A3 is critical for HIV-1 replication.
Erkelenz S; Hillebrand F; Widera M; Theiss S; Fayyaz A; Degrandi D; Pfeffer K; Schaal H
Retrovirology; 2015 Mar; 12():29. PubMed ID: 25889056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
